Inactive Instrument

JSR Corporation

Equities

JSCPY

US46632X1063

OMRON HEALTHCARE Co., Ltd. entered into an agreement to acquire Heartnote business of JSR Corporation from JSR Corporation.

Published on 10/10/2025

S&P Capital IQ

JSR CORPORATION

+1.04%

OMRON HEALTHCARE Co., Ltd. entered into an agreement to acquire Heartnote business of JSR Corporation from JSR Corporation on September 29, 2025.

The expected completion of the transaction is January 1, 2026.

Latest news about JSR Corporation

Feb. 26	ENEOS Corporation agreed to acquire Rubber sales business for the electronics industry of JSR Corporation.	CI
25-10-10	OMRON HEALTHCARE Co., Ltd. entered into an agreement to acquire Heartnote business of JSR Corporation from JSR Corporation.	CI
25-10-01	Stratasys Japan Co. Ltd. acquired D-Mec Ltd. from JSR Corporation.	CI
25-09-30	Tokuyama Corporation completed the acquisition of Vitro diagnostic pharmaceutical business from JSR Corporation.	CI
25-09-16	Lam Research and JSR Corporation Enter Cross- Licensing, Collaboration Agreement to Advance Semiconductor Manufacturing	CI
25-04-22	Tokuyama to Buy JSR's Diagnostics Unit for 82 Billion Yen	MT
25-04-21	Tokuyama Corporation agreed to acquire Vitro diagnostic pharmaceutical business from JSR Corporation for ¥82 billion.	CI
25-03-31	Nippon Shokubai Co., Ltd. completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation.	CI
24-11-13	JSR Seeks M&A	CI
24-11-13	JSR Corporation, H1 2025 Earnings Call, Nov 14, 2024
24-11-13	Japanese Shares Slide as Trump Tariff Concerns Spark Inflation Fears	MT
24-11-12	Japan's JSR to Build Metal Oxide Resist Plant in South Korea's Cheongju	MT
24-11-12	Nippon Shokubai to Acquire Emulsion Technology for 7.2 Billion Yen	MT
24-11-11	Nippon Shokubai Co., Ltd. agreed to acquire Emulsion Technology Co.,Ltd. from JSR Corporation for ¥7.2 billion.	CI

Chart JSR Corporation

Duration

Period

JSCPY: Dynamic Chart

Company Profile

JSR Corp mainly conducts digital solutions business, life science business and synthetic resin business. The Company operates in three business segments. The Digital Solution Business manufactures and sells semiconductor materials, display materials and edge computing related products. The Life Science segment is engaged in diagnostic and research reagents and materials, bioprocess materials and drug discovery support services. The Elastomers segment includes synthetic rubbers such as styrene and butadiene rubber, butadiene rubber, and ethylene and propylene rubber, refined processed products, thermoplastic elastomers and processed products, latexes for paper processing, latexes for general industrial use, acrylic emulsions, high-performance dispersants, as well as chemical products such as industrial particles, thermal insulation paint materials, battery materials, and butadiene monomers. The Synthetic Resin segment manufactures and sells acrylonitrile butadiene styrene (ABS) resins.

Employees

7,997

Sector

More about the company